Pfizer/BioNTech says three doses 'effective' against Omicron
Omicron counts more than 30 mutations on the spike protein that dots the surface of the coronavirus and allows it to invade cells.
Sat Dec 11 2021
Study suggests Pfizer COVID-19 vaccine may only partially protect against Omicron
There was "a very large drop" in neutralization of the Omicron variant relative to an earlier strain of COVID-19, Alex Sigal said.
Wed Dec 08 2021
BioNTech rancang buka ibu pejabat serantau dan kemudahan pembuatan mRNA di Singapura
BioNTech SE mengumumkan rancangan memperluas kedudukan globalnya ke Asia dengan penubuhan Ibu Pejabat Serantau untuk Asia Tenggara di Singapura.
Mon May 10 2021
BioNTech eyes COVID vaccine for 12-15 year olds from June in EU
Vaccinating children is seen as a crucial next step towards herd immunity and ending the pandemic.
Fri Apr 30 2021
Vaksin COVID-19: Pfizer yakin boleh melawan varian dari India
Pengeluar vaksin COVID-19 Pfizer-BioNtech yakin bahawa vaksin yang dihasilkannya berkesan untuk melawan varian dari India.
Thu Apr 29 2021
COVID-19: Turki umum lanjutkan selang antara dua dos vaksin
Menteri Kesihatan Fahrettin Koca memberitahu, keputusan diambil selepas perbincangan dengan Ketua Eksekutif BioNTech, Ugur Sahin.
Wed Apr 28 2021
Kejayaan hasil vaksin COVID-19, pasangan saintis dianugerah darjah tertinggi Jerman
Sahin dan Tureci dianugerahkan Darjah Kebesaran Merit Komandan Ksatria, iaitu salah satu penghormatan tertinggi yang diberikan oleh Jerman.
Sat Feb 27 2021
From the lab to the jab: how BioNTech-Pfizer won the vaccine race
It was over breakfast on the wintry morning of January 24 that Ozlem Tureci and her husband Ugur Sahin decided, "we need to fire the starting gun on this".
Sun Dec 27 2020
Production and delivery challenges set up turbulent Year of the Vaccine
Production of vaccine and delivery challenges suggest beating the disease will be a marathon whose finish line is still far away.
Wed Dec 23 2020
BioNTech CEO confident vaccine will work on UK variant
The variant, detected mainly in London and the southeast of England in recent weeks, has sparked concern worldwide because of signs that it may spread more easily.
Tue Dec 22 2020
COVID-19: Kelulusan vaksin di AS merupakan tonggak penting - CEO BioNTech
Ketua Pegawai Eksekutif BioNTech, Ugur Sahin memaklumkan, ia merupakan tonggak penting dan beliau gembira dengan keputusan tersebut.
Sat Dec 12 2020
With U.S. now in hand, BioNTech CEO looks for more vaccine production
The companies have said they will produce up to 1.3 billion doses of the vaccine next year.
Sat Dec 12 2020
What's next for Pfizer's COVID-19 vaccine after UK rollout
Pfizer has said it will not charge other developed countries a lower price for the vaccine than what the United States will pay.
Sat Dec 12 2020
Kehidupan boleh kembali normal sekiranya vaksin dapat digunakan secara meluas - Dr Sahin
Musim sejuk kali ini akan menjadi sukar sekiranya vaksin itu tidak memberi impak.
Mon Nov 16 2020
Vaccine scientist hopes for return to 'normal' by next winter
Ugur Sahin, the Turkish co-founder of German firm BioNTech, told the BBC's The Andrew Marr Show that "this winter will be hard" without any major impact from vaccinations.
Mon Nov 16 2020